Is Hysterosalpingo‐Contrast Sonography (<scp>HyCoSy</scp>) Using Sulfur Hexafluoride Microbubbles (<scp>SonoVue</scp>) Sufficient for the Assessment of Fallopian Tube Patency? A Systematic Review and Meta‐Analysis

Qu, Enze; Zhang, Man; Ju, Jinxiu; Chen, Ying; Lin, Xin; Zhang, Xinling

doi:10.1002/jum.15988

Cited by 3 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4D-HyCoSy has emerged as an important technique for assessing tubal patency due to its relative simplicity and cost-effectiveness ( 12 , 24 , 28 ). In our study, the sensitivity and specificity of 4D-HyCoSy for diagnosing tubal obstruction were 91.1% and 95.1%, respectively, which were consistent with previous research findings ( 29 , 30 ). The evaluation of tubal patency using 4D-HyCoSy depends on a comprehensive evaluation of the fallopian tubes, the contrast dispersion around the ovaries, and the contrast dispersion within the pelvis, which can lead to interobserver variability ( 10 , 14 , 31 , 32 ).…”

Section: Discussionsupporting

confidence: 92%

Evaluation of tubal patency based on peak injection pressure in four-dimensional hysterosalpingo-contrast sonography among infertile females: a preliminary study

Wang,

Chen,

et al. 2024

Quant Imaging Med Surg

View full text Add to dashboard Cite

Background Although the application of four-dimensional hysterosalpingo-contrast sonography (4D-HyCoSy) has relatively good diagnostic accuracy for assessing the patency of the fallopian tubes, the evaluation process mainly relies on morphological findings of the fallopian tubes and pelvic cavity. The purpose of this study was to explore the relationship of peak injection pressure during 4D-HyCoSy and tubal patency to provide a quantitative indicator for the evaluation of fallopian tube patency. Methods This study included infertile patients who underwent 4D-HyCoSy and laparoscopic chromopertubation (LC) between 2020 and 2022, with LC serving as the reference test for assessing tubal patency. For the HyCoSy procedure, the ultrasound contrast agent was injected automatically using a liquid injection machine, and real-time pressure values were recorded. Patients were classified based on tubal patency status in LC as bilaterally patent, unilaterally patent, or bilaterally nonpatent. The average peak injection pressure and contrast agent volume of different groups were compared. Receiver operating characteristic (ROC) curve analysis was employed to determine the cutoff value. Results A total of 268 infertile patients were enrolled in the study. With LC as the standard examination, the sensitivity and specificity of 4D-HyCoSy in diagnosing nonpatent fallopian tubes were 91.1% and 95.1%, respectively. In general, peak injection pressure was observed to gradually increase as tubal patency decreased (P<0.001), with average peak injection pressures of 233.5±66.3, 338.8±99.8, and 469.6±63.1 mmHg in the bilaterally patent, unilaterally patent, and bilaterally nonpatent groups, respectively. The volume of contrast agent used in patients in the bilaterally nonpatent group was significantly lower than that in the other two groups (P<0.01), with average volumes of 22.7±6.3, 24.3±9.3, and 18.9±9.2 mL, respectively. When one fallopian tube was patent, the area under the curve (AUC) for distinguishing obstruction from patency of the other fallopian tube was 0.827, with a sensitivity of 79.8% and a specificity of 74.3% (cutoff value: 254.3 mmHg). Similarly, when one fallopian tube was nonpatent, the AUC was 0.866, with a sensitivity of 90.6% and a specificity of 78.3% (cutoff value: 401.3 mmHg). Conclusions Peak injection pressure during 4D-HyCoSy demonstrates promising diagnostic performance in evaluating fallopian tube patency in infertile patients.

show abstract

Section: Discussionsupporting

confidence: 92%

Evaluation of tubal patency based on peak injection pressure in four-dimensional hysterosalpingo-contrast sonography among infertile females: a preliminary study

Wang,

Chen,

et al. 2024

Quant Imaging Med Surg

View full text Add to dashboard Cite

show abstract

“… Identify needle or confirm catheter position, delineate any cavity or duct, improve tracking of fistulae. Hysterosalpingography for confirming fallopian tube patency 13–15 Evaluate empyema complexity via chest tube injection 16 …”

Section: Indicationsmentioning

confidence: 99%

AIUM Practice Parameter for the Performance of Contrast‐Enhanced Ultrasound

2023

J of Ultrasound Medicine

View full text Add to dashboard Cite

IntroductionT he American Institute of Ultrasound in Medicine (AIUM) is a multidisciplinary association dedicated to advancing the safe and effective use of ultrasound in medicine through professional and public education, research, development of clinical practice parameters, and accreditation of practices performing ultrasound examinations.The AIUM Practice Parameter for the Performance of Contrast-Enhanced Ultrasound (CEUS) was revised by the AIUM in collaboration with other organizations whose members use ultrasound for performing this examination(s) (see "Acknowledgments"). Recommendations for personnel requirements, the request for the examination, documentation, quality assurance, and safety may vary among the organizations and may be addressed by each separately.This Practice Parameter is intended to provide the medical ultrasound community with recommendations for the performance and recording of high-quality ultrasound examinations. The parameters reflect what the AIUM considers the appropriate criteria for this type of ultrasound examination but are not intended to establish a legal standard of care. Examinations performed in this specialty area are expected to follow the Parameter with recognition that deviations may occur depending on the clinical situation. IndicationsIndications for CEUS are based on the current literature recommendations and clinical practice standards.Ultrasound (US) contrast agents and contrast-specific scanning techniques have extended the diagnostic capabilities of US. CEUS should be considered as a useful problem-solving tool and as an indicated first-line imaging modality in select settings as indicated below.Ultrasound contrast has no renal toxicity or clearance; therefore, CEUS may be used at any level of renal function. CEUS is often safe for patients with contraindications to computed

show abstract

Fundamentos de la ecografía con contraste: farmacodinámica y farmacocinética del contraste. Bases de la imagen de ecografía con contraste

Fontanilla Echeveste,

Ripollés González,

Aguirre Pascual

2024

Radiología

View full text Add to dashboard Cite

Is Hysterosalpingo‐Contrast Sonography (HyCoSy) Using Sulfur Hexafluoride Microbubbles (SonoVue) Sufficient for the Assessment of Fallopian Tube Patency? A Systematic Review and Meta‐Analysis

Cited by 3 publications

References 30 publications

Evaluation of tubal patency based on peak injection pressure in four-dimensional hysterosalpingo-contrast sonography among infertile females: a preliminary study

Evaluation of tubal patency based on peak injection pressure in four-dimensional hysterosalpingo-contrast sonography among infertile females: a preliminary study

AIUM Practice Parameter for the Performance of Contrast‐Enhanced Ultrasound

Fundamentos de la ecografía con contraste: farmacodinámica y farmacocinética del contraste. Bases de la imagen de ecografía con contraste

Contact Info

Product

Resources

About